All Stories

Patient suffers side effect in Cabaletta autoimmune CAR-T trial, but analysts unfazed

Analysts appeared unfazed by the news that a patient treated with Cabaletta Bio’s autoimmune CAR-T suffered a toxicity complication during a phase 1/2 trial.

Apr 2, 2025 - 12:01
 0
Patient suffers side effect in Cabaletta autoimmune CAR-T trial, but analysts unfazed
Analysts appeared unfazed by the news that a patient treated with Cabaletta Bio’s autoimmune CAR-T suffered a toxicity complication during a phase 1/2 trial.
Read More

Tags:

Previous Article

New trims cut Lotus Emeya, Eletre starting prices by £5760

Next Article

As tariffs loom, Honda ranks high on several measures of 'American-made'

Related Posts

Clario continues acquisition spree with imaging specialist NeuroRx

Clario continues acquisition spree with imaging special...

Mar 18, 2025  0

Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic

Latigo saddles up with $150M to spur non-opioid pain dr...

Mar 17, 2025  0

New AI-discovered protein compounds kill bacteria and fungi infecting mice: study

New AI-discovered protein compounds kill bacteria and f...

Feb 9, 2025  0